Targovax to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition
Oslo, 28 June 2021 – Targovax ASA, today announces that Victor Levitsky, Chief Scientific Officer of Targovax, is invited to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition. 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition, virtualDate: 29 June 2021Presenter: Victor Levitsky (CSO)Time: 14:15 EDT / 20:15 CETTitle: Clinical efficacy and immuno-modulatory properties of oncolytic adenovirus ONCOS-102 ***